Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Atherosclerosis

• Publication date

  2014-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2014.04.035PMID 24859635PMCID PMC4095745
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• HIV Disease Activity as a Modulator of Lipoprotein(a) and Allele-Specific Apolipoprotein(a) Levels

  2013cited by this paper
• In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a).

  2012cited by this paper
• Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.

  2011cited by this paper
• Lipoprotein(a) as a cardiovascular risk factor: current status

  2010cited by this paper
• Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.

  2010cited by this paper
• Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.

  2009cited by this paper
• Genetic variants associated with Lp(a) lipoprotein level and coronary disease.

  2009cited by this paper
• Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.

  2009cited by this paper
• Extreme Lipoprotein(a) Levels and Risk of Myocardial Infarction in the General Population: The Copenhagen City Heart Study

  2008cited by this paper
• High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.

  2008cited by this paper
• Lipoprotein(a) and its position among other risk factors of atherosclerosis.

  2008cited by this paper
• Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations.

  2007cited by this paper
• Lipoprotein(a) and LDL Particle Size Are Related to the Severity of Coronary Artery Disease

  2007cited by this paper
• In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.

  2007cited by this paper
• Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease

  2006cited by this paper
• Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol Published, JLR Papers in Press, August 3, 2006.

  2006cited by this paper
• The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings.

  2005cited by this paper
• Comparison of the effects of three different (-)-hydroxycitric acid preparations on food intake in rats

  2005cited by this paper
• Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage

  2003cited by this paper
• apoA- AND apoB-CONTAINING LIPOPROTEINS AND Lp(A) CONCENTRATION IN NON-DIALYZED PATIENTS WITH CHRONIC RENAL FAILURE

  2002cited by this paper
• Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia DOI 10.1194/jlr.M100435-JLR200

  2002influential reference
• Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians.

  2002cited by this paper
• Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.

  2001cited by this paper
• The metabolism of lipoprotein(a) and other apolipoprotein B-containing lipoproteins: a kinetic study in humans.

  2001cited by this paper
• Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.

  2000cited by this paper
• High Levels of Lp(a) With a Small Apo(a) Isoform Are Associated With Coronary Artery Disease in African American and White Men

  2000cited by this paper
• Predictors of plasma lipoprotein(a) concentration in the West of Scotland Coronary Prevention Study cohort.

  1999cited by this paper
• Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay.

  1996cited by this paper
• John Henryism, education, and blood pressure in young adults. The CARDIA study. Coronary Artery Risk Development in Young Adults Study.

  1996cited by this paper
• Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women.

  1994cited by this paper
• Measurement of apolipoproteins A-I and B during the National Health and Nutrition Examination Survey (NHANES) III.

  1994cited by this paper
• Comparison of serum lipoprotein(a) distribution and its correlates among black and white populations.

  1994cited by this paper
• Lipoprotein (a) in a randomly selected 25-64 year old population: the Northern Sweden Monica Study.

  1993cited by this paper
• Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study.

  1993cited by this paper
• Molecular definition of the extreme size polymorphism in apolipoprotein(a).

  1993cited by this paper
• The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.

  1993cited by this paper
• Effects of Age, Sex, and Menopausal Status on Plasma Lipoprotein(a) Levels The Framingham Offspring Study

  1993cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• Lp(a) lipoprotein: Relationship to cardiovascular disease risk factors, exercise and estrogen

  1992cited by this paper
• Effect of weight loss on serum lipoprotein(a) concentrations in an obese population.

  1991cited by this paper
• Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA.

  1990cited by this paper
• Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

  1989cited by this paper
• Black-white differences in serum Lp(a) lipoprotein levels.

  1987cited by this paper
• New assay of apolipoproteins A-I and B by rate nephelometry evaluated.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a).

  1986cited by this paper
• Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B

  1985cited by this paper
• A peroxidase-coupled method for the colorimetric determination of serum triglycerides.

  1983cited by this paper
• Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

  1982cited by this paper
• Enzymatic determination of total serum cholesterol.

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• O R I G I N a L I N V E S T I G a T I O N Open Access

  year unknowncited by this paper

• APOE genotype and the effect of statins on lipid outcomes: A meta-analysis.

  2026cites this paper
• Apolipoprotein B outperforms low density lipoprotein particle number as a marker of cardiovascular risk in the UK Biobank.

  2025cites this paper
• Lipoprotein(a) and the risk of recurrent coronary heart disease: the Dubbo Study

  2023cites this paper
• Influence of triglyceride concentration in lipoprotein (a) as a function of dyslipidemia.

  2023cites this paper
• Lipoprotein (a) as a Biomarker for Cardiovascular Diseases and Potential New Therapies to Mitigate Risk.

  2023cites this paper
• Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics

  2021cites this paper
• Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target

  2021cites this paper
• Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

  2020cites this paper
• Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials.

  2019cites this paper
• Molecular Nutrition Fats

  2019cites this paper
• Schimke immunoosseous dysplasia and management considerations for vascular risks

  2019cites this paper
• apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study

  2019cites this paper
• Proprotein convertase subtilisin/kexin type 9 inhibitors and lipoprotein(a)-mediated risk of atherosclerotic cardiovascular disease: more than meets the eye?

  2019cites this paper
• Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women’s Interagency HIV Study[S]

  2018cites this paper
• Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

  2018cites this paper
• Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease

  2017influential citation
• LDL-cholesterol Predicts a First CHD Event in Senior Citizens, Especially So in Those With Elevated Lipoprotein(a): Dubbo Study of the Elderly.

  2017cites this paper
• The roles of apo(a) size, phenotype, and dominance pattern in PCSK9-inhibition-induced reduction in Lp(a) with alirocumab[S]

  2017cites this paper
• [Elevated Lipoprotein(a) Cncentration and Presence of Subfractions of Small Dense Low Density Lipoproteins as Independent Factors of Risk of Ischemic Heart Disease].

  2016cites this paper
• Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation

  2015cites this paper
• PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)

  2015cites this paper
• Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores

  2015cites this paper
• A Study of Nontraditional Biochemical Markers and Their Relation to the Level of Fasting Glycemia in Patients with Type 2 Diabetes Mellitus Tip 2 Diabetes

  year unknowncites this paper